Cassandra X
The answer to why we haven’t got funding
Cassandra X
The answer to why we haven’t got funding from the government is simple - we didn’t apply for it. NP said they are a small company and too busy right now.
He feels that if our drug is approved funding will be available then - he might be right but it is very easy to explain why we haven’t been funded.
I actually think that this is a mistake - if you believe in your product and don’t at least ask for funding but i am not the ceo.
IMO
3
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Big Leap for Military Power on the Go Seems like Epsilor just raised the stakes in the military tech race with their latest 6T battery, a piece of kit boasting some serious muscle at 4,400Wh with 174Ah thrown in for good measure. Serving up a military-grade solution where endurance and performance are necessities, they've entered production just in time for the...
Continue Reading
STANLEY® Floors: The New Frontier? Who would've thought STANLEY®, the tool giant founded back in 1843, would dive headfirst into the flooring market? This isn’t just any leap; it's a strategic handshake with Area Floors, and they’re dragging along i4F’s renowned drop-lock tech for good measure. What does this mean for the flooring landscape and STANLEY's brand...
Continue Reading
Vanda Pharmaceuticals Heads Into Key Investor Spotlights In the relentless quest for market edge, Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is setting the stage for what could be some telling moments in September 2026. Investors with a keen interest in the pharmaceutical realm should seat themselves upfront as Vanda takes the floor in a series of pivotal conferences. Each...
Continue Reading
Revolutionizing Healthcare Payment with AI Ah, healthcare and payments—two things that can make even the most patient folks lose their cool. But here comes Codoxo, shaking up this landscape with its Point Zero Payment Integrity solution, and someone's finally giving them the nod they deserve. For those of us who have been in the game for a while, this announcement is...
Continue Reading
Gone are the days when a flimsy monochrome badge was all that stood between a visitor and unrestricted access. Today, Epson and STOPware rock the boat with their new collaboration, offering a game-changing approach to security with full-color badge printing. This isn't just a vanity upgrade; it's about real security enhancement creating immediate visual cues. Shifting the...
Continue Reading
Amidst the hullabaloo of the reinsurance world, Corgi Insurance is attempting something rather bold. They're flinging open the doors to innovation with a new brainchild, Corgi Re, promising to shake off the dust from an industry that still clings to the bygone era of spreadsheets and marathon underwriting cycles. The aim? Fire up modern underwriting technology and...
Continue Reading
The Future of Education Shaped Today There's a profound shift happening in higher education, and it's not the usual undergrad grind most folks think of. Cate Tolnai, stepping into her role at the University of Phoenix, is in the thick of it. She's set to join the UPCEA Council for Credential Innovation's leadership team, and that isn't some fluff title. Her appointment...
Continue Reading
Quick and Unexpected Moves at Mega Matrix Just when you thought things couldn't get more complicated in the world of Mega Matrix Inc. (NYSE: MPU), they pull a rabbit out of the hat at their Extraordinary General Meeting on September 1st. Held at their office in Singapore, shareholders green-lighted some heavy-hitting changes like a share consolidation—twenty into one...
Continue Reading
Shareholder Endorsement Solidifies Check Point's Strategy Today, Check Point Software Technologies had a bit of a celebratory mood. Their stakeholders, it seems, aren't just riding the wave; they're all in. You could almost hear the cheers from Redwood City when those shareholder voting results flashed across the board. Some 81.2 million shares—encompassing about 79.52%...
Continue Reading
Costa Rica's Big Stage for Business and Opportunity You might look at Costa Rica and think of lush rainforests and coffee beans, but right now, it's a hub bustling with suits, spreadsheets, and strategic meetings. Over three days, the Costa Rica Trade & Investment Summit (CRTIS) gathered nearly half a thousand buyers and investors all under one roof in San José. Local...
Continue Reading
Top 5 Most Recently Viewed Articles
Explore Sable Run: Affordable Living Awaits Century Communities is thrilled to introduce Sable Run, a vibrant new community set to offer accessible homeownership options for families and individuals. With prices beginning in the $300s, Sable Run intends to fulfill the growing demand for modern and affordable housing. Stunning Home Designs This community features two...
Continue Reading
IM Alliance Conference Promises Revolutionary Insights This year, the Independent Medical Alliance (IMA) is preparing to host its 4th Annual Conference with a pivotal theme that speaks volumes about the future of healthcare. Titled "Honest Medicine: Redefining Health," this event will take place from April 4-6 in a bustling setting. With a robust lineup of leading medical...
Continue Reading
Transformative Growth in Mobile Application Market The global mobile application market is anticipated to show substantial growth, with a predicted increase of USD 2.63 trillion from 2025 to 2029. The remarkable growth trajectory is attributed to the expanding smartphone penetration and advancements in technology, particularly artificial intelligence (AI) and machine...
Continue Reading
Orezone Gold's Ambitious Expansion Plan Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) recently made headlines with its bold move to fully exercise its over-allotment option related to a significant financing deal. By doing so, they secured an additional 6,402,450 common shares at a price of C$0.82 per share, which generated gross proceeds of C$5,250,009. Strategic Use...
Continue Reading
ASP Isotopes Inc. Public Offering Announcement In a significant move, ASP Isotopes Inc. (NASDAQ: ASPI) has announced the pricing of its underwritten public offering of common stock. The company plans to sell a total of 2,395,000 shares, priced at $6.75 each. This offering is projected to generate approximately $16.2 million for ASP Isotopes, before accounting for...
Continue Reading